ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Foon Moves To UPCI

April 18, 2003